AnaptysBio
ANAB
ANAB
147 hedge funds and large institutions have $816M invested in AnaptysBio in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
18% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 55
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
147
Holding in Top 10
4
Calls
$5.28M
Puts
$2.89M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$17.4M | |
| 3 | +$7.81M | |
| 4 |
6CM
683 Capital Management
New York
|
+$6.76M |
| 5 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
+$5.94M |
Top Sellers
| 1 | -$40.7M | |
| 2 | -$24.3M | |
| 3 | -$24.2M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$13.9M |
| 5 |
BlackRock
New York
|
-$8.65M |
